- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
< Back to Bio
Joseph Akrotirianakis (Joe)
View all
Joseph Akrotirianakis (Joe)
News 21 results
Recognition
October 13, 2021
Benchmark Litigation Recognizes King & Spalding as a Leading Litigation Firm
Recognition
July 2, 2021
The American Lawyer Names Joe Akrotirianakis a West Trailblazer
In the News · Source: Southeast Takeaways
June 15, 2021
Joe Akrotirianakis and Arwen Johnson discuss how associates need to be intentional in managing their careers
In the News · Source: Law360, Daily Journal, Bloomberg Law, Law.com, Law360, Global Arbitration Review and The Recorder
Events 1 results
Conference
November 12, 2019
12th Annual King & Spalding Pharmaceutical University
Insights 2 results
Article · Source: Daily Journal
May 20, 2020
Price gouging: A hidden danger of the pandemic
Article · Source: Law360
November 20, 2018
Circuit Split Encourages Forum Shopping By Injured Seamen